$2.71
-0.04[-1.45%]
At close: Apr 24
$2.71
0[0.00%]
After Hours: 7:51PM EDT
Arbutus Biopharma
(NASDAQ:ABUS)Arbutus Biopharma Stock (NASDAQ:ABUS), Earnings Estimates, EPS, and Revenue
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$-0.110
Quarterly Revenue Estimate
$2.1M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$18.1M
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | AM | ABUS | Q1 | -$0.10 | -$0.11 | — | — | $6.69M | $2.15M | — | — | Get Alert |
| 02/29/2024 | AM | ABUS | Q4 | -$0.14 | -$0.12 | -$0.12 | 0.00% | $6.25M | $4.79M | $2.15M | -55.22% | Get Alert |
| 11/07/2023 | AM | ABUS | Q3 | -$0.12 | -$0.11 | -$0.12 | -9.09% | $5.95M | $4.75M | $4.66M | -1.94% | Get Alert |
| 08/03/2023 | AM | ABUS | Q2 | -$0.10 | -$0.12 | -$0.10 | 16.67% | $14.24M | $5.02M | $4.65M | -7.35% | Get Alert |
| 05/04/2023 | AM | ABUS | Q1 | -$0.11 | -$0.14 | -$0.10 | 28.57% | $12.58M | $6.03M | $6.69M | 10.90% | Get Alert |
| 03/02/2023 | AM | ABUS | Q4 | -$0.15 | -$0.13 | -$0.14 | -7.69% | $3.21M | $6.17M | $6.25M | 1.22% | Get Alert |
| 11/09/2022 | AM | ABUS | Q3 | -$0.24 | -$0.13 | -$0.12 | 7.69% | $3.34M | $9.37M | $5.95M | -36.48% | Get Alert |
| 08/04/2022 | AM | ABUS | Q2 | -$0.23 | -$0.13 | -$0.10 | 23.08% | $2.33M | $6.77M | $14.24M | 110.35% | Get Alert |
| 05/05/2022 | AM | ABUS | Q1 | -$0.21 | -$0.16 | -$0.11 | 31.25% | $2.11M | $4.37M | $12.58M | 187.89% | Get Alert |
| 03/03/2022 | AM | ABUS | Q4 | -$0.23 | -$0.19 | -$0.15 | 21.05% | $2.39M | $2.87M | $3.21M | 11.71% | Get Alert |
| 11/04/2021 | AM | ABUS | Q3 | -$0.27 | -$0.24 | -$0.24 | 0.00% | $1.52M | $2.38M | $3.34M | 40.34% | Get Alert |
| 08/05/2021 | AM | ABUS | Q2 | -$0.25 | -$0.22 | -$0.23 | -4.55% | $1.51M | $2.12M | $2.33M | 9.86% | Get Alert |
| 05/05/2021 | AM | ABUS | Q1 | -$0.25 | -$0.23 | -$0.21 | 8.70% | $1.49M | $3.31M | $2.11M | -36.16% | Get Alert |
| 03/04/2021 | AM | ABUS | Q4 | -$0.46 | -$0.22 | -$0.23 | -4.55% | $1.62M | $1.96M | $2.39M | 21.73% | Get Alert |
| 11/05/2020 | AM | ABUS | Q3 | -$0.73 | -$0.22 | -$0.27 | -22.73% | $3.10M | $1.66M | $1.52M | -8.25% | Get Alert |
| 08/07/2020 | AM | ABUS | Q2 | -$0.46 | -$0.24 | -$0.25 | -4.17% | $700.00K | $1.74M | $1.51M | -12.99% | Get Alert |
| 05/11/2020 | AM | ABUS | Q1 | -$0.47 | -$0.39 | -$0.25 | 35.90% | $700.00K | $220.00K | $1.49M | 577.73% | Get Alert |
| 03/05/2020 | AM | ABUS | Q4 | -$0.37 | -$0.39 | -$0.46 | -17.95% | $1.60M | $220.00K | $1.62M | 635.45% | Get Alert |
| 11/06/2019 | AM | ABUS | Q3 | -$0.30 | — | -$0.73 | — | $1.60M | — | $3.10M | — | Get Alert |
FAQ
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma (ABUS) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Arbutus Biopharma (NASDAQ:ABUS)?
The Actual EPS was $-0.12, which hit the estimate of $-0.12.
What were Arbutus Biopharma’s (NASDAQ:ABUS) revenues?
The Actual Revenue was $2.1M, which missed the estimate of $4.8M.
Browse earnings estimates, EPS, and revenue on all stocks.